Answered You can buy a ready-made answer or pick a professional tutor to order an original one.
Paper Topic: COPD 1. Introduction (Identification of the problem) with a clear presentation of the problem as well as the significance and a scholarly overview of the paper’s content. No heading is us
Paper Topic: COPD
1. Introduction (Identification of the problem) with a clear presentation of the problem as well as the significance and a scholarly overview of the paper’s content. No heading is used for the Introduction per APA currentedition.
2. Background and Significance of the disease, to include: Definition, description, signs and symptoms. Incidence and prevalence of statistics by state with a comparison to national statistics pertaining to the disease (state: South Carolina; also create a table) If after a search of the library and scholarly data bases, you are unable to find statistics for your home state, or other states, consider this a gap in the data and state as much in the body of the paper. For instance, you may state something like, “After an exhausting search of the scholarly data bases, this writer is unable to locate incidence and/or prevalence data for the state of South Carolina. This indicates a gap in surveillance that will be included in the “Plan” section of this paper.
3. Surveillance and Reporting: Current surveillance methods and mandated reporting processes as related to the chronic health condition chosen should be specific.
4. Epidemiological Analysis: Conduct a descriptive epidemiology analysis of the health condition. Be sure to include all of the 5 W’s: What, Who, Where, When, Why. Use details associated with all of the W’s, such as the “Who” which should include an analysis of the determinants of health. Include costs (both financial and social) associated with the disease or problem.
5. Screening and Guidelines: Review how the disease is diagnosed and current national standards(guidelines). Use this link: https://www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/guide/cpsguide.pdf and review its sensitivity, specificity, predictive value, and cost.
6. Plan: Integrating evidence, provide a plan of how a nurse practitioner will address this chronic health condition after graduation. Provide three specific interventions that are based on the evidence and include how you will measure outcomes (how will you know that the interventions have utility, are useful?) Note: Consider primary, secondary, and tertiary interventions as well as the integration of health policy advocacy efforts. All interventions should be based on evidence – connected to a resource such as a scholarly piece of research.
7. Summary/Conclusion: Conclude in a clear manner with a brief overview of the keys points from each section of the paper utilizing integration of resources.
8. The paper should be formatted and organized into the following sections which focus on the chosen chronic health condition. (Page length 7 - 10 pages; excluding title page and references).
- @
- 1943 orders completed
- ANSWER
-
Tutor has posted answer for $45.00. See answer's preview
********************* *********** ********* ******* ******************************* Number:Course ******************** ******** ************************************************ people ** the current society *** exposed to ********* ***** *** other ********* chemicals ***** *** ******* ********* ***** of ******** The ***** ** ******* ** ********* its ******* economy ** various ******* *** ********* without paying attention to the ******* ** their ******* ******* *********** ********* Disease (COPD) is one ** *** ******* ** ********* ************* pollution ***** has *** **** ******** ****** ** *** *** **** *** ***** parts of the ***** ******* ** ** 2011) This research ***** **** ** ********** various ******* ******* be *********** scholars ***** ******** ***** ******** ********** ** ***** ** ********** *** ******* ****** This **** be done with *** *** ** ********* ********** ****** **** the ********** ** how ** ****** patients *** **** ** ****** *** *************** ** *** diseaseDefinitionCOPD is * ******* ******* which ******* one’s lungs through *********** normal airflow **** *** ***** ** ****** *** ** ********** difficulties **** ****** ** ******* ***** ***** **** *** infected ********** ***** ****** oxygen ****** into the body **** one ******** COPD ***** is * **** chance that **** **** ** exposed ** ***** chronic ******** **** as **** ****** ***** ******* and other ***** ** ******** which weakens *** ************** ***************** ** the diseaseFor the ******* ** attack ** ********** *** is ***** exposed ** ********* *** chronic bronchitis conditions ***** lead ** ****** ********** when ******** ******** However *** ******* ** the *** ********** **** ********* ** ******* **** ******** composition This ***** **** some ****** ***** ** ******** affected ***** others ***** **** ****** ****** ******* signs of **** **************** bronchitis attacks *** ****** ** *** ********* ***** ***** ************ This affects *** *** that ** being ******* **** *** **** *** sacs ** the ***** *** who has been ******** *** * dry cough and **** ******** ***** ** a ********** manner Emphysema on *** ***** hand ******** *********** ***** ****** **** *** ** ******* to ********* smoke *** other ***** ***** are harmful to *** ******** ** * ********* ******* to *** ******** individuals ******* ** ** ********* ** note **** ** *** ** ******* *** ******** ********** ** ******** ** manage ***** ******** and also ** reducing one’s ******** ** ***** ***** of ******** **** as ***** disease *** ****** ***** *** ****** ******* ** ***** for *** *********** ** **** *** patient *** *** *********** *** symptoms of COPD *** ********* infections ******* an individual ******* **** ***** vary from ****** ** ****** ********* ** ***** body ******** ************ In **** ***** *** ******** *** persist *** several **** ***** also depends ** *** **** ******** *********** *** also *** stage ** ***** the ******** ****** *** ******** One experiences ***** ******* ***** ****** ****** **** *** *** ***** **** in a ******** ******** **** ***** that *** ***** are struggling ** *** *** ** *** *** ** the *** ****** Wheezing ***** ******* **** the blockage ** *** ******* *** experiences ***** tightness4 *** *********** * ******* ***** which ***** to ********** of ***** *** mucus *** be clear ****** ******** or ***** ** color5 One ** diagnosed with *********** ********** *********** *** *** ******* ****** to carry on **** ******** activities7 When ** ****** ****** one starts ** lose body ******* ******* **** **** and ****** starts to swellStatistics *** *** disease ** South *********** group ***************************************************** *** *************************************************************************************************** ******************************************************************** ** ************* ***** **** ***** * ********** ******* ******* ****** of people *** the **** of infection which has **** presented ** ********** **** ******* *** **** ** *** ****** ** ******** ******** ********** ** ******* ***** ********** a research from *** work ********* ** ******* scholars *** ********** *** *** ***** **** which ******** **** ********* rate between Carolina *** other *************** *** surveillance ********** *********** ******** ** **** **** *** ********* ******* ******** ************ *** periodic **************** ******* *** *** case ** ******** surveillance ** ********* ** ********* cases with **** *** accomplished ******* other conditions **** *** ********** ** *** surveillance This *********** to * ******** ***** of *** targeted ********** For periodic **************** ******* *** ******** details **** ******** ** ***** to ********* ******* the **** ********* displayed regularity ** **** ** data ********* ** ******** *** **** ** ****** *** *********** ** *** dataEpidemiological ************ ** ***** ** what ****** *** ******* it ** important ** **** **** ** has ******** the ********** *** ***** *** main ***** of the disease is **** ** ****** *** ** * ********* ** *** ********** **** and **** slowness **** ** ***** to ******** carbon ******* from *** ***** *** ******* ********** ** *** *** ** the ***** ********* to ******** over **** *** ** most cases it becomes ************ ***** et ** ***** ********* ** ******** ************** ******* ** *** **** ***** ** the ******* ******* evidence ***** that * **** low ********** ** ********** **** acquired *** ******* ***** *** ***** ******* ***** might ****** *** ********** ** ** infection ***** ******** environmental ********* *** their occupation Other factors ******** ********* **** ***** *** ***** ** * low ************* statusMen *** ***** **** ***** chances ** ********* **** the ******* ***** **** 88% ********** ** ********* **** the disease while ******* have *** ***** shows ****** ******* ******* Around ** ** *** ***** **** a ********** ** ***** infected while ******* **** * likelihood ** ** *** data ******* on white **** Other populations *** also ******** ********** ***** ***** ******* ** environments ******* the lungsWhen ** ***** ** **** **** might not ** * key trend ** *** ***** ****** **** *** disorder ***** ***** ******* **** infectious conditions for several decades ******* ********* ** *** ******** Morbidity Surveys **** ***** *** females aged ******* 65 ** ** ***** **** *** ******* ********** ** ***** ********* with *** ********* The condition might ***** showing ** ** this *** after *** ******** **** been ******* ** ********** **** ** smoking *** ******* ********** *** has **** ********* **** *** ********* 50% of *** ********** dies ****** a ****** ** ** ***** due ** ***** related to *********** insufficiency In **** ***** ******** *** *** exposed ** environmental pollution ***** ***** diagnosed **** *** ********* **** * higher ****** ** ***** ******* *** ** **** of ********** oxygen ********** ** ***** to *********** *** costs ** ********* ** ** ********* ** note that *** treatment *** ** ********** ** two **** *** **** ** ********* *** ** **** ****** early ****** ***** being infected whereby *** ********** goes ******* ********* such ** ** **** ******* A **** **** ******* can ** ******* which ******** minimizing ******* *** also ********** a relapse of *** ******** **** ******** therapeutic ********* ** ** *** as ***** *** **** ******* **** *** ******* *** **** ********* **** *** ****** ***** the ******** *** severe *** ** *** **** **** *** ******* is ** * ****** risk *** cost ** maintaining **** * ******* ** ****** $5037 per year ***** *** have been ********* with stage three *** at the ******* **** The **** of ******** **** a ******* ** ****** ****** per **** It ** **** important ** **** that **** ** ********** *** **** ********* with *** ********* the **** aim ** treatment ******** ** ** slow **** the *********** of *** ******* ** *** ** *** financial ****** ****** around *** ******* *** ****** ** **** * ****** ************** ** order to assist *** ******* especially in ***** ***** **** ****** ****** ******** activities *** patient also needs ************* **** ****** ** order ** ****** **** *** *** ********* *** treatment also aims ******* ********** *** **** ********** ** *** infected ********** *** to ****** *** **** ** ********** ***** is ****** ** ********* exposure ** *** ******* ******* ********** ****** **** ******* chemical compositions ***** ***** that * ******** ****** ****** ** ********** ** *** ultimate form ** ********* *** ******** ******* ************* **** are ****** ***** *** **** depending ** their efficiency ** the ******* being treated ********** clinical ****** *** done ** ***** ** ********* *** ********** ** each method **** **** diagnosisIn **** * ******* ******* the ******** ** *** ******* ** is ********* ** *** *** doctor *** doctor ******** * spirometry ***** involves ********* *** *********** breathing rate *** ******* ** **** there *** ***** ** *** ******* ******* ******** ** the ******* is ********* ***** ******** **** *** **** ** ********* *** *********** **** ***** ******** checking ****** ** bluish color ** *** *********** **** *** also the ********* **** ********* et al ***** *** *********** concentration ***** ** **** ******** ** **** **** *** ************* ********* *** to ******* ****** levels in the ************ ***** has * role ** ********** ** ******** of COPD ***** **** *** ** done ******* *** ***** ****** ** prevention that is the ******* secondary *** ******** ************ ************** ***** **** ** *** populations ***** has *** **** ********* *** *** ***** can ******* people **** *** ** *** ***** on the ******* of ******* **** can **** ** ******* ****** ***** platforms *** aim ** to *** *** ********** ** interact with **** will happen ***** **** **** **** ********* **** the ********* The ***** can **** ******** *** ****** working ********** especially ** ******* free ******* zones **** will reduce *** **** ** acquiring *** ******* ** ******************** ************* ***** *** assist *** ********** ***** has ******* **** ******** ** ******** **** on ways ** ******** ******* **** **** ******** ******** them ** take ******* ***** ** ***** ** assess *** ****** ** *** ******* *** **** aim ** the nurse ** **** stage is to **** down *** ****** ** *** ******* **** ** individual *** **** ******** *** ***** *** **** advise the patient ** *** type ** ************ that **** ****** expose ********** **** ********** due ** *** ***** ** ***** ************* ************** ******** methods ** ********** *** *********** life ********** especially ** ******** *** have **** ********* **** stage ***** ** the ********* This includes letting **** ********** the **** of ***** ***** **** should ******* and ***** ** ******** ********* which **** should **** **** ** *** ***** can **** ***** *** ****** members ** *** measures that they ****** take ** order to support *** patient ******** ***** **** 2019)ConclusionChronic *********** pulmonary ******* *** ** ********* ******* ********** * ******* ********* *** ******* *** **** ********* in the society *** years ******* it has ****** ******** ****** in **** ***** ******** *** *** old *** *** ****** should be ** the ***** **** **** ** ***** to ********* *** society ** **** **** *** ** ***** to ****** the ***** ******* ** *** ******* *** also ******** ***** can ** ***** ** ***** to ***** ******** *** ******* ***** **** ******** *********** family ******* ****** **** part ** ********* **** through *** ******** ***************************************************** * ***** Hogg * * ****** ****** ** *** pathogenesis ** ******* *********** pulmonary diseaseNew England ******* ** Medicine381(13) ********* https://wwwnejmorg/doi/full/101056/NEJMra1900475Brandsma C A *** *** Berge * Hackett * L Brusselle * ***** ****** * (2020) Recent ******** ** ******* *********** ********* ******* ************* from ******* ********** to precision *********** Journal of *************** ******* ********************************************************* ******* *********** ********* Disease: **** ***** ****** in South ******** https://wwwcdcgov/copd/maps/docs/pdf/SC_COPDFactSheetpdfLowe * * ***** E * Anzueto A Austin E ****** J * ***** T * & ***** * * ****** ********** ***** ********** the ********* ** ******* *********** pulmonary ************** *********** ********* ********* ******* ** *** **** ************** 384 https://wwwncbinlmnihgov/pmc/articles/PMC7020846/McLean * ******** * Liu * * ******** C *** * ***** ****** * (2011) Telehealthcare *** chronic obstructive ********* *************** ******** of ********** ******* (7) ***************************************************************************